HETEROAROMATIC COMPOUNDS

The specification relates to compounds of Formula (I) and to pharmaceutically acceptable salts thereof, to processes and intermediates used for their preparation, to pharmaceutical compositions containing them and to their use in the treatment of diseases such as chemotherapy induced peripheral neur...

Full description

Saved in:
Bibliographic Details
Main Authors BOSTRÖM, Stig Jonas, PALOMERO VAZQUEZ, Maria Angel, BRECCIA, Perla, JARVIS, Rebecca Elizabeth
Format Patent
LanguageEnglish
French
Published 20.06.2024
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The specification relates to compounds of Formula (I) and to pharmaceutically acceptable salts thereof, to processes and intermediates used for their preparation, to pharmaceutical compositions containing them and to their use in the treatment of diseases such as chemotherapy induced peripheral neuropathy (CIPN). L'invention concerne des composés de formule (I) et des sels pharmaceutiquement acceptables de ceux-ci, des procédés et des intermédiaires utilisés pour leur préparation, des compositions pharmaceutiques les contenant, et leur utilisation dans le traitement de maladies telles que la neuropathie périphérique chimio-induite (CIPN).
Bibliography:Application Number: WO2023EP86034